APA (7th ed.) Citation

Arustamyan, M., Kibrik, P., Hatipoglu, D., Bungo, B., Mentias, A., Hill, B. T., & Moudgil, R. (2022). The safety of Bruton's tyrosine kinase inhibitors in B‐cell malignancies: A systematic review. European Journal of Haematology, 109(6), 696. https://doi.org/10.1111/ejh.13854

Chicago Style (17th ed.) Citation

Arustamyan, Michael, Pavel Kibrik, Dilara Hatipoglu, Brandon Bungo, Amgad Mentias, Brian T. Hill, and Rohit Moudgil. "The Safety of Bruton's Tyrosine Kinase Inhibitors in B‐cell Malignancies: A Systematic Review." European Journal of Haematology 109, no. 6 (2022): 696. https://doi.org/10.1111/ejh.13854.

MLA (9th ed.) Citation

Arustamyan, Michael, et al. "The Safety of Bruton's Tyrosine Kinase Inhibitors in B‐cell Malignancies: A Systematic Review." European Journal of Haematology, vol. 109, no. 6, 2022, p. 696, https://doi.org/10.1111/ejh.13854.